Trials / Conditions / Leukemia, Myelogenous, Acute

Leukemia, Myelogenous, Acute

5 registered clinical trials studyying Leukemia, Myelogenous, Acute.

Status	Trial	Sponsor	Phase
Completed	LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia NCT01999556	Wake Forest University Health Sciences	—
Terminated	A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS NCT01085656	University of Florida	Phase 1
Terminated	Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia NCT01158885	Therapeutic Advances in Childhood Leukemia Consortium	Phase 2
Terminated	Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) NCT01106950	Masonic Cancer Center, University of Minnesota	Phase 2
Completed	Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies NCT00619879	Ann & Robert H Lurie Children's Hospital of Chicago	—